Join us for our monthly support group followed by an Info Session and Q&A about Metrodora Institute with Metrodora CEO Dr. Laura Pace (see more details below!). Our support group will meet from 1:00-1:45pm, and then our guest speaker will join us from 1:45-2:15!
Support group: 1:00-1:45pm
Join us for our monthly support group for dysautonomia patients and caregivers living in the Los Angeles area. Our support group provides a space for patients to share their experiences related to dysautonomia, as well as an opportunity to provide and receive support from others living with this condition. This meeting will take place in a virtual format via Zoom. Please email LADN.home@gmail.com if you are interested in attending and would like to receive the meeting link.
Support Group Disclaimer:
Please note this is a community organized support group. It is not facilitated by a licensed medical or mental health professional. Talk with your doctor before implementing any advice from the group.
Metrodora Info Session and Q&A with Dr. Laura Pace: 1:45-2:15pm
Join us for an informational session and Q&A about Metrodora Institute, a new destination medical and research center located in Salt Lake City, UT. The Institute is focused on advancing care and accelerating the path to improved diagnostics, therapeutics, and ultimately, cures, for complex neuroimmune axis disorders. Metrodora Institute CEO and Co-Founder, Dr. Laura Pace will discuss Metrodora's new model for coordinated clinical care, current and future research programs, and Metrodora's approach to treating multisystem conditions such as dysautonomia and co-morbid conditions.
About Dr. Pace: Dr. Laura Pace is a physician-scientist with over 20 years of clinical and research experience. She is a leading neruogastroenterologist specializing in autonomic disorders, genetics, as well as rare and undiagnosed diseases. Dr. Pace has published over 100 peer-reviewed journals and serves as a co-investigator of the NIH Undiagnosed Disease Network (UDN), as well as Principal Investigator for the Argenx Alpha Study, a clinical trial studying an existing therapeutic for the treatment of post-COVID POTS. A fierce patient advocate, she is also a Medical Board member for Dysautonomia International and Chair of the Gastrointestinal Working Group for the International Consortium of Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders.